Aug 28, 2026 07:00AM
Aug 28, 2026 07:00AM
Aug 26, 2026 06:45AM
Aug 26, 2026 06:45AM
Aug 18, 2026 12:57PM
Aug 12, 2026 09:15AM
Aug 12, 2026 05:57AM Lilly files six lawsuits over illegal sales of unapproved retatrutide
Aug 12, 2026 05:30AM
Aug 5, 2026 06:45AM
Aug 3, 2026 07:45AM
Aug 3, 2026 07:45AM
Jul 23, 2026 06:45AM
Jul 23, 2026 06:45AM
Jul 16, 2026 10:00AM Oppenheimer on AtaiBeckley Inc (ATAI): 'LLY Acquisition Validates Psychedelic Advantages'
Jul 16, 2026 06:45AM
Jul 16, 2026 06:45AM
Jul 15, 2026 10:42AM
Jul 14, 2026 02:27PM
Jul 13, 2026 03:27PM
Jul 9, 2026 07:31AM
Jul 9, 2026 07:30AM Lilly to present Alzheimer's disease diagnostic and therapeutic research at AAIC 2026, including new data on P-tau217 blood tests and amyloid-targeting treatment
Jul 9, 2026 07:30AM
Jul 1, 2026 09:05AM
Jun 29, 2026 04:29PM
Jun 29, 2026 04:20PM
Jun 29, 2026 06:14AM
Jun 26, 2026 07:17AM
Jun 26, 2026 07:16AM Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
Jun 25, 2026 06:45AM
Jun 22, 2026 09:05AM
Jun 22, 2026 09:00AM
Jun 14, 2026 08:05AM
Jun 14, 2026 03:15AM
Jun 10, 2026 09:30AM
Jun 9, 2026 06:19PM FDA approves Lilly's EBGLYSS for eight-week dosing in atopic dermatitis
Jun 9, 2026 06:18PM
Jun 8, 2026 02:31PM
Jun 8, 2026 02:30PM
Jun 8, 2026 02:56AM
Jun 7, 2026 11:00AM
Jun 6, 2026 02:53PM
Jun 6, 2026 02:30PM Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and i
Jun 4, 2026 08:03AM
Jun 2, 2026 09:30AM
Jun 2, 2026 09:30AM
Jun 1, 2026 02:53AM
May 31, 2026 11:21PM
May 31, 2026 08:01AM
May 28, 2026 01:00PM Lilly to present diabetes, obesity drug data at ADA conference
May 28, 2026 01:00PM

329,625 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All